Orange Book product · Brand (NDA)
NINLARO
IXAZOMIB CITRATE
At a glance
Nov 20, 2015
Approved
Brand (NDA)
Application
Not listed
TE code
7
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 20, 2015
10 yr 9 mo ago
Today
Patent 7687662 expires
Listed drug substance patent expiration.
Aug 06, 2027
in 1 yr 2 mo
Patent 8003819 expires
Listed drug substance patent expiration.
Aug 06, 2027
in 1 yr 2 mo
Patent 8530694 expires
Listed drug substance patent expiration.
Aug 06, 2027
in 1 yr 2 mo
Patent 8871745 expires
Listed method-of-use patent (U-2434) expiration.
Aug 06, 2027
in 1 yr 2 mo
Patent 8859504 expires
Listed drug substance patent expiration.
Jun 16, 2029
in 3 yr
Patent 9175017 expires
Listed method-of-use patent (U-2434) expiration.
Jun 16, 2029
in 3 yr
Patent 7442830 expires
Listed drug substance patent expiration.
Nov 20, 2029
in 3 yr 6 mo
Pharmaceutical detail
Active ingredient
IXAZOMIB CITRATE
Strength
EQ 3MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 208462
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (7)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7687662 | Aug 06, 2027 | in 1 yr 2 mo | SubstanceProduct |
| 8003819 | Aug 06, 2027 | in 1 yr 2 mo | SubstanceProductU-2434 |
| 8530694 | Aug 06, 2027 | in 1 yr 2 mo | SubstanceProductU-2434 |
| 8871745 | Aug 06, 2027 | in 1 yr 2 mo | U-2434 |
| 8859504 | Jun 16, 2029 | in 3 yr | SubstanceProduct |
| 9175017 | Jun 16, 2029 | in 3 yr | U-2434 |
| 7442830 | Nov 20, 2029 | in 3 yr 6 mo | SubstanceProductU-2434 |
